MVK PHARMACEUTICALS

MVK Pharmaceuticals is an early-stage drug development company that has completed positive preclinical trials and is in the process of submitting an IND package to the FDA to begin Phase I human studies. The company seeks to advance a first-in-class treatment of suicidal ideation with major depression through intranasal delivery of a three amino acid neuropeptide loaded in a biodegradable nanoparticle. Success will launch a pipeline of drugs for various treatments that range from PTSD, TBI, anxiety, sleep, addictions, epilepsy, and other disorders... MVK Pharmaceuticals is committed to advancing current treatments for PTSD hallmarked by anxiety, depression, drug and alcohol abuse, and sleep disorders... MVK Pharmaceutical's is a unique veteran owned pharmaceutical company seeking to help military members, their families, veterans, and civilians beat suicide and other mental health disorders.

Primary location: Indianapolis United States